KRAS and neoplasm: Further, using immunohistochemistry and genetic analysis techniques to evaluate biliary epithelial markers, tissue structure, genetic aberrations (including KRAS mutations), transcriptome, and microRNA profiles a high degree of gene consistency between the primary tumor and the 4th generation PDX model was confirmed.